RESMED INC — Director's Dealing 2013

Sep 11, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-09-09

Reporting Person: PACE GARY W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-09-09	ResMed Common Stock	M	12000	$23.095	Acquired	89273	Direct
2013-09-09	ResMed Common Stock	S	12000	$50.051	Acquired	77273	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-09	ResMed Stock Options	$23.095	M	12000	Disposed	2013-11-10	ResMed Common Stock (12000)	Direct

Footnotes

F1: Represents the first date options become exercisable. Options vest 1/12 each month with a 3 year holding period from date of grant.

F2: This transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F3: This transaction was executed in multiple trades at prices ranging from $50.01 to $50.09. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.